###begin article-title 0
Autotaxin, a synthetic enzyme of lysophosphatidic acid (LPA), mediates the induction of nerve-injured neuropathic pain
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin p 2
###xml 230 231 230 231 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 266 268 266 268 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 283 286 283 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 286 287 286 287 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 287 291 287 291 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 386 389 386 389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 389 390 389 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 389 390 389 390 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 390 394 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1025 1035 1025 1035 <italic xmlns:xlink="http://www.w3.org/1999/xlink">autotaxin </italic>
###xml 1041 1044 1041 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 1044 1047 1044 1047 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 1399 1402 1395 1396 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 1449 1452 1443 1446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 1452 1453 1446 1447 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 1452 1453 1446 1447 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 1453 1457 1447 1451 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1485 1488 1479 1482 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 1488 1492 1482 1486 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1599 1601 1593 1595 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1715 1717 1709 1711 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 246 250 <span type="species:ncbi:10090">mice</span>
###xml 291 295 <span type="species:ncbi:10090">mice</span>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
###xml 786 790 <span type="species:ncbi:10090">mice</span>
###xml 1012 1016 <span type="species:ncbi:10090">mice</span>
###xml 1138 1142 <span type="species:ncbi:10090">mice</span>
###xml 1457 1461 <span type="species:ncbi:10090">mice</span>
###xml 1492 1496 <span type="species:ncbi:10090">mice</span>
Recently, we reported that lysophosphatidic acid (LPA) induces long-lasting mechanical allodynia and thermal hyperalgesia as well as demyelination and upregulation of pain-related proteins through one of its cognate receptors, LPA1. In addition, mice lacking the LPA1 receptor gene (lpa1-/- mice) lost these nerve injury-induced neuropathic pain behaviors and phenomena. However, since lpa1-/- mice did not exhibit any effects on the basal nociceptive threshold, it is possible that nerve injury-induced neuropathic pain and its machineries are initiated by LPA via defined biosynthetic pathways that involve multiple enzymes. Here, we attempted to clarify the involvement of a single synthetic enzyme of LPA known as autotaxin (ATX) in nerve injury-induced neuropathic pain. Wild-type mice with partial sciatic nerve injury showed robust mechanical allodynia starting from day 3 after the nerve injury and persisting for at least 14 days, along with thermal hyperalgesia. On the other hand, heterozygous mutant mice for the autotaxin gene (atx+/-), which have 50% ATX protein and 50% lysophospholipase D activity compared with wild-type mice, showed approximately 50% recovery of nerve injury-induced neuropathic pain. In addition, hypersensitization of myelinated A- or Adelta-fiber function following nerve injury was observed in electrical stimuli-induced paw withdrawal tests using a Neurometer(R). The hyperalgesia was completely abolished in lpa1-/- mice, and reduced by 50% in atx+/- mice. Taken together, these findings suggest that LPA biosynthesis through ATX is the source of LPA for LPA1 receptor-mediated neuropathic pain. Therefore, targeted inhibition of ATX-mediated LPA biosynthesis as well as LPA1 receptor and its downstream pathways may represent a novel way to prevent nerve injury-induced neuropathic pain.
###end p 2
###begin title 3
Findings
###end title 3
###begin p 4
###xml 196 197 196 197 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1</sub>
###xml 207 208 207 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 221 222 221 222 <sub xmlns:xlink="http://www.w3.org/1999/xlink">3</sub>
###xml 229 230 229 230 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 231 232 231 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 251 253 251 253 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 402 403 402 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 566 568 566 568 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 643 645 643 645 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 750 752 750 752 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 989 990 989 990 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 991 992 991 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1060 1062 1060 1062 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 1333 1334 1333 1334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1335 1336 1335 1336 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 235 239 <span type="species:ncbi:10090">Mice</span>
Lysophosphatidic acid (LPA) is a representative lipid mediator that has a variety of biological actions, including roles in cell proliferation, migration and survival via its cognate receptors LPA1/EDG2, LPA2/EDG4 and LPA3/EDG7 [1-4]. Mice lacking LPA1 receptor do not develop any signs of neuropathic pain, demyelination or upregulation of pain-related gene/protein expression following nerve injury [5]. Nerve injury-induced neuropathic pain and its underlying machineries are caused by a single intrathecal (i.t.) injection of LPA, and blocked by knockdown of LPA1 receptor at the early, but not late, stage. These findings suggest that LPA1 receptor activation initiates the machineries of neuropathic pain. Furthermore, since deletion of the LPA1 receptor gene did not have any effect on the basal nociceptive threshold, it is evident that nerve injury-induced neuropathic pain and its machineries are initiated by LPA via defined biosynthetic pathways that involve multiple enzymes [6,7]. Therefore, targeted inhibition of LPA biosynthesis as well as LPA1 receptor would be a valuable way to prevent nerve injury-induced neuropathic pain. Autotaxin (ATX), which was originally identified as a tumor cell motility factor, is known to have lysophospholipase D (lysoPLD) activity and convert lysophosphatidylcholine (LPC) to LPA [8,9]. Here, we report the involvement of ATX in the development of partial sciatic nerve injury-induced neuropathic pain.
###end p 4
###begin p 5
###xml 38 48 38 48 <italic xmlns:xlink="http://www.w3.org/1999/xlink">autotaxin </italic>
###xml 54 57 54 57 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 57 60 57 60 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 63 65 63 65 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 91 94 91 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 94 96 94 96 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 94 96 94 96 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 102 105 102 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 105 106 105 106 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 106 109 106 109 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 112 114 112 114 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 574 576 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 738 740 730 732 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 876 877 868 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 878 880 870 872 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1281 1282 1273 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 1283 1285 1275 1277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1727 1729 1719 1721 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 2167 2168 2158 2159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 25 29 <span type="species:ncbi:10090">mice</span>
###xml 78 82 <span type="species:ncbi:10090">mice</span>
###xml 154 158 <span type="species:ncbi:10090">mice</span>
###xml 218 222 <span type="species:ncbi:10090">mice</span>
###xml 624 628 <span type="species:ncbi:10090">mice</span>
###xml 1288 1292 <span type="species:ncbi:10090">Mice</span>
###xml 1922 1927 <span type="species:ncbi:10090">mouse</span>
Male heterozygous mutant mice for the autotaxin gene (atx+/-) [10] and mutant mice for the lpa1 gene (lpa1-/-) [11], which were backcrossed with C57BL/6J mice at least ten times before use, and their sibling wild-type mice weighing 20-24 g from the same genetic background were used. They were kept in a room maintained at 21 +/- 2degreesC with free access to a standard laboratory diet and tap water. All procedures were approved by the Nagasaki University Animal Care Committee and complied with the recommendations of the International Association for the Study of Pain [12]. Partial ligation of the sciatic nerve of the mice was performed under pentobarbital (50 mg/kg i.p.) anesthesia, following the methods of Malmberg and Basbaum [13]. In thermal paw withdrawal tests, nociception was measured as the latency to paw withdrawal evoked by exposure to a thermal stimulus [5,14]. Unanesthetized animals were placed in plexiglas cages on top of a glass sheet and an adaptation period of 1 hour was allowed. A thermal stimulator (IITC Inc., Woodland Hills, CA, USA) was then positioned under the glass sheet and the focus of the projection bulb was aimed exactly at the middle of the plantar surface of a particular paw. Paw pressure tests were performed as described previously [5,15]. Mice were placed into a plexiglas chamber on a 6 x 6-mm wire mesh grid floor and allowed to acclimatize for 1 hour. A mechanical stimulus was then delivered onto the middle of the plantar surface of the right hindpaw using a Transducer Indicator (Model 1601; IITC Inc., Woodland Hills, CA, USA). Electrodes (Neurotron Inc., Baltimore, MD) were attached to the right plantar surface and instep of a particular paw, as previously described [16]. Transcutaneous nerve stimuli with two sine-wave pulses (250 and 2000 Hz) were applied using a Neurometer CPT/C (Neurotron Inc. Blatimore, MD, USA). The minimum intensity (muA) at which each mouse withdrew its paw was defined as the current stimulus threshold. Stimuli were applied at 10-minute intervals. Investigators blinded to the phenotype of a gene carried out all experiments. Statistical analyses were performed using Student's t-test. Significance was set at p < 0.05.
###end p 5
###begin p 6
###xml 66 69 66 69 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 69 72 69 72 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 202 204 202 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 242 243 242 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 328 331 328 331 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 331 334 331 334 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/-</sup>
###xml 351 354 351 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 354 357 354 357 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 443 446 443 446 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 446 450 446 450 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 463 466 463 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 466 470 466 470 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 493 496 493 496 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 496 500 496 500 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 556 559 556 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 559 563 559 563 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 571 574 571 574 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 574 578 574 578 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 595 598 595 598 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 598 602 598 602 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 816 818 816 818 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 74 78 <span type="species:ncbi:10090">mice</span>
###xml 359 363 <span type="species:ncbi:10090">mice</span>
###xml 450 454 <span type="species:ncbi:10090">mice</span>
###xml 470 474 <span type="species:ncbi:10090">mice</span>
###xml 500 504 <span type="species:ncbi:10090">mice</span>
###xml 563 567 <span type="species:ncbi:10090">mice</span>
###xml 578 582 <span type="species:ncbi:10090">mice</span>
###xml 602 606 <span type="species:ncbi:10090">mice</span>
In paw pressure tests, partial sciatic nerve injury in wild-type (atx+/+) mice caused robust mechanical allodynia starting from day 3 after the nerve injury and persisting until at least day 14 (Figure 1A), consistent with a previous report [5]. There was no significant difference in the basal thresholds between heterozygous (atx+/-) and wild-type (atx+/+) mice. As shown in Figure 1A, the degree of mechanical allodynia was less evident in atx+/- mice than in atx+/+ mice. The threshold in atx+/- mice with injury was between the level in sham-operated atx+/+ mice or atx+/- mice and that in atx+/+ mice with injury, and the differences from these other groups were statistically significant for at least 14 days. Similar results were observed when nerve injury-induced thermal hyperalgesia was evaluated (Figure 1B).
###end p 6
###begin p 7
###xml 40 43 40 43 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 43 47 43 47 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 0 51 0 51 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Partial blockade of neuropathic pain in <italic>atx</italic><sup>+/- </sup>mice</bold>
###xml 121 124 121 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 124 128 124 128 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 433 436 426 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 436 437 429 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 436 437 429 430 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 437 441 430 434 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 449 452 442 445 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 452 456 445 449 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 128 132 <span type="species:ncbi:10090">mice</span>
###xml 460 464 <span type="species:ncbi:10090">mice</span>
###xml 683 687 <span type="species:ncbi:10090">mice</span>
###xml 723 727 <span type="species:ncbi:10090">mice</span>
Partial blockade of neuropathic pain in atx+/- mice. (A, B) Partial blockade of mechanical allodynia and hyperalgesia in atx+/- mice. Paw pressure tests (A) were carried out on days 3, 7 and 14 after the nerve injury, while thermal paw withdrawal tests (B) were carried out on day 14 after the nerve injury. (C, D) Complete and partial blockade of Abeta (2000 Hz)- and Adelta (250 Hz)-fiber stimulation-induced hypersensitivities in lpa1-/- (C) and atx+/- (D) mice, respectively. Behavior experiments were carried out on days 7 and 14 (C) and day 14 (D) after the nerve injury. All data represent the mean +/- SEM from 5-6 separate experiments. *p < 0.05 compared with sham-operated mice; #p < 0.05 compared with wild-type mice with nerve injury.
###end p 7
###begin p 8
###xml 178 181 178 179 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174;</sup>
###xml 291 293 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 315 317 313 315 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 319 329 317 327 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 486 489 480 483 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 489 491 483 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1 </italic>
###xml 489 491 483 485 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1 </italic></sub>
###xml 491 495 485 489 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+ </sup>
###xml 544 547 538 541 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 547 548 541 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 547 548 541 542 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 548 551 542 545 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/+</sup>
###xml 674 676 667 669 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 678 688 671 681 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 783 786 776 779 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 786 787 779 780 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 786 787 779 780 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 787 791 780 784 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 883 886 876 879 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 886 887 879 880 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 886 887 879 880 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 887 891 880 884 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1052 1055 1045 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 1055 1059 1048 1052 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1140 1142 1133 1135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 1144 1154 1137 1147 <italic xmlns:xlink="http://www.w3.org/1999/xlink">left panel</italic>
###xml 1329 1332 1318 1321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 1332 1333 1321 1322 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 1332 1333 1321 1322 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 1333 1337 1322 1326 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 1349 1353 1338 1342 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1396 1398 1385 1387 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1403 1405 1392 1394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 1407 1419 1396 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">right panels</italic>
###xml 495 499 <span type="species:ncbi:10090">mice</span>
###xml 553 557 <span type="species:ncbi:10090">mice</span>
###xml 777 781 <span type="species:ncbi:10090">mice</span>
###xml 791 795 <span type="species:ncbi:10090">mice</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 891 895 <span type="species:ncbi:10090">mice</span>
###xml 1059 1063 <span type="species:ncbi:10090">mice</span>
###xml 1337 1341 <span type="species:ncbi:10090">mice</span>
###xml 1353 1357 <span type="species:ncbi:10090">mice</span>
We previously developed a nociceptive test (EPW test) to evaluate nociceptive paw-withdrawal behavior in response to electrical stimuli with different frequencies in a Neurometer(R), an apparatus that selectively activates sensory neurons by using sine-wave pulses of different frequencies [16]. As shown in Figure 1C (left panel), the threshold for paw withdrawal upon 2000-Hz electrical stimulation, which is supposed to stimulate Abeta fibers, was approximately 320 muA in wild-type lpa1 +/+ mice. Partial sciatic nerve injury in wild-type (lpa1+/+) mice caused a significant decrease in the withdrawal threshold to 2000 muA at day 7, which persisted until day14 (Figure 1C, left panel). Although there was no significant difference in the basal thresholds between knockout mice (lpa1-/- mice) and wild-type mice, the hypersensitivity was completely abolished at days 7 and 14 in lpa1-/- mice. On the other hand, the hypersensitivity to 2000-Hz electrical stimulation at day 14 after the nerve injury was partially, but significantly, attenuated in atx+/- mice, which showed no significant change in the threshold without injury (Figure 1D, left panel). Quite similar results were observed when the withdrawal responses induced by 250-Hz electrical stimulation, which is supposed to stimulate Adelta fibers, were evaluated in lpa1-/- mice and atx+/- mice with and without nerve injury (Figure 1C and 1D, right panels).
###end p 8
###begin p 9
###xml 30 33 30 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 33 37 33 37 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 69 72 69 72 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 72 76 72 76 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/- </sup>
###xml 157 159 157 159 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 339 341 339 341 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 404 407 404 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 407 411 407 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 581 583 581 583 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 616 618 616 618 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 639 640 639 640 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 57 61 <span type="species:ncbi:10090">mice</span>
###xml 94 98 <span type="species:ncbi:10090">mice</span>
###xml 192 196 <span type="species:ncbi:10090">mice</span>
###xml 333 337 <span type="species:ncbi:10090">mice</span>
###xml 424 428 <span type="species:ncbi:10090">mice</span>
In the present study, we used atx+/- heterozygous mutant mice, since atx-/- homozygous mutant mice were reported to die at the early stage of embryogenesis [10]. Therefore, these heterozygous mice are expected to have half the level of ATX expression, and indeed they were reported to show 50% lysoPLD activity relative to wild-type mice [10]. This finding is consistent with the present study, in which atx+/- heterozygous mice showed partial attenuation of nerve injury-induced neuropathic pain, as observed for conventional mechanical allodynia and thermal hyperalgesia (Figure 1A), which are mediated through LPA1 receptor activation [5].
###end p 9
###begin p 10
###xml 138 140 138 140 <sup xmlns:xlink="http://www.w3.org/1999/xlink">2+</sup>
###xml 512 514 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 681 683 659 661 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 711 713 689 691 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 844 847 815 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 847 851 818 822 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 1127 1129 1098 1100 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2 </sub>
###xml 1133 1134 1104 1105 <sub xmlns:xlink="http://www.w3.org/1999/xlink">2</sub>
###xml 1137 1138 1108 1109 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1139 1140 1110 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 864 868 <span type="species:ncbi:10090">mice</span>
On the other hand, nerve injury is known to cause functional changes in myelinated A-fibers, such as demyelination, and upregulation of Ca2+channel alpha2delta-1 subunits and sodium channels in medium/large neurons of the dorsal root ganglion would underlie the molecular mechanisms for neuropathic pain. Previously, we demonstrated that nerve injury causes hypersensitization of myelinated Abeta- and Adelta-fiber functions in an electrical stimuli-induced paw flexion (EPF) test, which is a modified EPW test [17]. Here, we found that hypersensitization of myelinated Abeta- and Adelta-fiber functions following nerve injury was observed in the EPW test, and mediated through LPA1 receptor activation (Figure 1C). Consequently, we carried out further tests to clarify the involvement of ATX in Abeta- and Adelta-fiber hypersensitization. The atx+/- heterozygous mice showed significant and partial attenuation of these phenomena. It is well known that LPA is mainly produced via two major pathways, namely LPC conversion mediated by activation of ATX and phosphatidic acid conversion mediated by activation of phospholipase A2 (PLA2) [6,7]. However, all the findings in the present report suggest that nerve injury-induced LPA production mainly occurs through LPC conversion mediated by activation of ATX.
###end p 10
###begin p 11
###xml 88 90 88 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 460 462 460 462 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 533 536 533 536 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lpa</italic>
###xml 536 537 536 537 <italic xmlns:xlink="http://www.w3.org/1999/xlink">1</italic>
###xml 536 537 536 537 <sub xmlns:xlink="http://www.w3.org/1999/xlink"><italic>1</italic></sub>
###xml 537 540 537 540 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 570 573 570 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 573 577 573 577 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 603 605 603 605 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 540 544 <span type="species:ncbi:10090">mice</span>
###xml 597 601 <span type="species:ncbi:10090">mice</span>
There are reports that LPC is produced under physiological and pathological conditions [18,19]. Furthermore, LPC treatment of the saphenous or sciatic nerve induced neuropathic pain-like behaviors, such as mechanical allodynia and thermal hyperalgesia, as well as demyelination and upregulation of pain-related proteins in the dorsal root ganglion [20]. More recently, we found that i.t. injection of LPC induces neuropathic pain-like behaviors through ATX-LPA1 receptor signaling, since these behaviors were completely abolished in lpa1-/-mice and partially blocked in atx+/- heterozygous mutant mice [21]. Therefore, LPC is involved in neuropathic pain.
###end p 11
###begin p 12
###xml 82 84 82 84 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 169 171 169 171 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 241 242 241 242 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 506 508 506 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
We previously reported that i.t. injection of an antisense oligonucleotide for LPA1 receptor or inhibitors of RhoA/ROCK, one of the downstream signaling molecules of LPA1 receptor, completely abolished nerve injury-induced neuropathic pain [5]. Furthermore, i.t. injection of LPA mimics nerve injury-induced neuropathic pain. Therefore, nerve injury seems to cause LPA production in the spinal cord. ATX protein is present in the cerebrospinal fluid (CSF) and has lysoPLD activity to convert LPC into LPA [22]. On the other hand, LPC is not present in CSF [22]. Therefore, nerve injury would produce LPC in the spinal cord, which would subsequently be hydrolyzed by ATX to form LPA. Experiments to evaluate LPA and LPC production following nerve injury and clarify the relationship of ATX to LPA production are the next important issues to be addressed.
###end p 12
###begin p 13
###xml 164 166 164 166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 311 312 311 312 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 387 390 387 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">atx</italic>
###xml 390 394 390 394 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+/- </sup>
###xml 394 398 <span type="species:ncbi:10090">mice</span>
In addition to the lysoPLD activity to convert LPC to LPA, ATX also possesses activity to convert sphingosylphosphorylcholine to bioactive sphingosine-1-phosphate [23]. However, we previously reported that i.t. injection of sphingosine-1-phosphate did not cause neuropathic pain-like allodynia or hyperalgesia [5]. These findings suggest that the marked reduction of neuropathic pain in atx+/- mice can be attributed to a reduction in LPA production following nerve injury.
###end p 13
###begin p 14
###xml 90 92 90 92 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
###xml 206 208 206 208 <sub xmlns:xlink="http://www.w3.org/1999/xlink">1 </sub>
In summary, we have demonstrated that LPA biosynthesis by ATX is the source of LPA for LPA1 receptor-mediated neuropathic pain. Therefore, targeted inhibition of ATX-mediated LPA biosynthesis as well as LPA1 receptor and its downstream pathways may represent a novel way to prevent nerve injury-induced neuropathic pain.
###end p 14
###begin title 15
Acknowledgements
###end title 15
###begin p 16
This work was supported by MEXT KAKENHI (17109015 to HU; 18689010 to MI) and an NIH grant (NS048478 to JC).
###end p 16
###begin article-title 17
###xml 72 79 <span type="species:ncbi:8355">Xenopus</span>
Lysophosphatidates bound to serum albumin activate membrane currents in Xenopus oocytes and neurite retraction in PC12 pheochromocytoma cells
###end article-title 17
###begin article-title 18
Signalling and crosstalk of Rho GTPases in mediating axon guidance
###end article-title 18
###begin article-title 19
Lysophosphatidic acid induces neuronal shape changes via a novel, receptor-mediated signaling pathway: similarity to thrombin action
###end article-title 19
###begin article-title 20
Lysophosphatidic acid (LPA) is a novel extracellular regulator of cortical neuroblast morphology
###end article-title 20
###begin article-title 21
Initiation of neuropathic pain requires lysophosphatidic acid receptor signaling
###end article-title 21
###begin article-title 22
Mechanisms of lysophosphatidic acid production
###end article-title 22
###begin article-title 23
Regulation and biological activities of the autotaxin-LPA axis
###end article-title 23
###begin article-title 24
###xml 18 23 <span type="species:ncbi:9606">human</span>
Identification of human plasma lysophospholipase D, a lysophosphatidic acid-producing enzyme, as autotaxin, a multifunctional phosphodiesterase
###end article-title 24
###begin article-title 25
Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production
###end article-title 25
###begin article-title 26
Autotaxin stabilizes blood vessels and is required for embryonic vasculature by producing lysophosphatidic acid
###end article-title 26
###begin article-title 27
Requirement for the lpA1 lysophosphatidic acid receptor gene in normal suckling behavior
###end article-title 27
###begin article-title 28
Ethical guidelines for investigations of experimental pain in conscious animals
###end article-title 28
###begin article-title 29
###xml 36 41 <span type="species:ncbi:10090">mouse</span>
Partial sciatic nerve injury in the mouse as a model of neuropathic pain: behavioral and neuroanatomical correlates
###end article-title 29
###begin article-title 30
A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia
###end article-title 30
###begin article-title 31
Novel expression of vanilloid receptor 1 on capsaicin-insensitive fibers accounts for the analgesic effect of capsaicin cream in neuropathic pain
###end article-title 31
###begin article-title 32
Inhibition of paclitaxel-induced A-fiber hypersensitization by gabapentin
###end article-title 32
###begin article-title 33
Characterization of three different sensory fibers by use of neonatal capsaicin treatment, spinal antagonism and a novel electrical stimulation-induced paw flexion test
###end article-title 33
###begin article-title 34
Immunological mechanisms in atherosclerosis
###end article-title 34
###begin article-title 35
Role of lysophosphatidylcholine in the inhibition of endothelial cell motility by oxidized low density lipoprotein
###end article-title 35
###begin article-title 36
Focal lysolecithin-induced demyelination of peripheral afferents results in neuropathic pain behavior that is attenuated by cannabinoids
###end article-title 36
###begin article-title 37
Lysophosphatidylcholine induces neuropathic pain through an action of autotaxin to generate lysophosphatidic acid
###end article-title 37
###begin article-title 38
Identification of autotaxin as a neurite retraction-inducing factor of PC12 cells in cerebrospinal fluid and its possible sources
###end article-title 38
###begin article-title 39
Autotaxin hydrolyzes sphingosylphosphorylcholine to produce the regulator of migration, sphingosine-1-phosphate
###end article-title 39

